4
Changes in Ownership
Olema Oncology, Inc. Filed Acc 0001415889-24-029027
CH. DISCOV. & NON-CLIN DEV OFF sold 26,066 shares at an average $9.01 ($234,916)
- CH. DISCOV. & NON-CLIN DEV OFF acquired 48,750 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | 2024-12-09 | Grant or award | +48,750 | 624,399 | D | ||
| Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | 2024-12-10 | Sale | −12,452 | $9.38 | $116,800 | 611,947 | D |
| Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | 2024-12-11 | Sale | −13,314 | $8.66 | $115,299 | 598,633 | D |
| Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | 2024-12-11 | Sale | −300 | $9.39 | $2,817 | 598,333 | D |
| Open-market sales · 26,066 sh · avg $9.01 · $234,916 | |||||||
Loading xslF345X05/form4-12122024_121200.xml…